CGON vs IT · $4.74B cap vs P/E 16, rev $6.27B
CG Oncology, Inc. Common stock (CGON) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
CGON does not have a complete income-statement cache yet.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
CGON currently screens at market cap $4.74B. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the CGON and IT stock pages for the full models.
Not investment advice.